Phage display technology provides a powerful tool for the development of novel recombinant antibodies. In this work, we optimized and streamlined the recombinant antibody discovery process for haptens as an example. A multi-immunization approach was used in order to avoid the need for construction of multiple antibody libraries. Selection methods were developed to utilize the full potential of the recombinant antibody library by applying four different elution conditions simultaneously. High-throughput immunoassays were used to analyse the binding properties of the individual antibody clones. Different carrier proteins were used in the immunization, selection, and screening phases to avoid enrichment of the antibodies for the carrier protei...
7noDuring the last 20 years in vitro technologies opened powerful routes to combine the generation o...
Techniques developed over the past 20 years for the display of foreign peptides and proteins on the ...
During the last 15 years in vitro technologies opened powerful routes to combine the generation of l...
Phage display technology provides a powerful tool for the development of novel recombinant antibodie...
Phage display technology provides a powerful tool for the development of novel recombinant antibodie...
The development of antibodies to low molecular weight haptens remains challenging due to both the lo...
More and more recombinant antibodies specific for haptens such as drugs of abuse, dyes and pesticide...
Recently, we constructed a focused antibody library tailored to interact with haptens. High function...
Antibody phage display technology is well established and widely used for selecting specific antibod...
Antibody phage display technology is well established and widely used for selecting specific antibod...
ABSTRACT: Production of antibodies has been revolutionized by the development of modern molecular bi...
ABSTRACT: Production of antibodies has been revolutionized by the development of modern molecular bi...
Phage display bypasses the immune response by bringing the entire immune repertoire to a target anti...
Phage display bypasses the immune response by bringing the entire immune repertoire to a target anti...
Picloram-specific variable fragments (V(HH)s) of heavy chain antibodies (HCAbs) were selected from a...
7noDuring the last 20 years in vitro technologies opened powerful routes to combine the generation o...
Techniques developed over the past 20 years for the display of foreign peptides and proteins on the ...
During the last 15 years in vitro technologies opened powerful routes to combine the generation of l...
Phage display technology provides a powerful tool for the development of novel recombinant antibodie...
Phage display technology provides a powerful tool for the development of novel recombinant antibodie...
The development of antibodies to low molecular weight haptens remains challenging due to both the lo...
More and more recombinant antibodies specific for haptens such as drugs of abuse, dyes and pesticide...
Recently, we constructed a focused antibody library tailored to interact with haptens. High function...
Antibody phage display technology is well established and widely used for selecting specific antibod...
Antibody phage display technology is well established and widely used for selecting specific antibod...
ABSTRACT: Production of antibodies has been revolutionized by the development of modern molecular bi...
ABSTRACT: Production of antibodies has been revolutionized by the development of modern molecular bi...
Phage display bypasses the immune response by bringing the entire immune repertoire to a target anti...
Phage display bypasses the immune response by bringing the entire immune repertoire to a target anti...
Picloram-specific variable fragments (V(HH)s) of heavy chain antibodies (HCAbs) were selected from a...
7noDuring the last 20 years in vitro technologies opened powerful routes to combine the generation o...
Techniques developed over the past 20 years for the display of foreign peptides and proteins on the ...
During the last 15 years in vitro technologies opened powerful routes to combine the generation of l...